Brigatinib is a drug that targets a protein called ALK. It’s used to treat a specific type of lung cancer that has spread. It stops the ALK pathway, which helps cancer cells grow and spread.
You can get it in tablet forms of 30 mg, 90 mg, or 180 mg. You start with 90 mg a day for the first week, then go up to 180 mg after that. It comes in bottles with 30 tablets each.
